NON-INVASIVE DETOXIFICATION TREATMENT IN THE PREVENTION OF MILD GESTOSIS
Summaries: According to the research, including enterosorbtion by polypefan into treatment of gestational toxicosis im-proves clinico-laboratory indicators – decrease of the rate of weight gain, increase of daily diuresis, absence of the protein in the urine, stabilizes systolic and especially diastolic blood pressure, decreases heart rate and decreases leukocytic index of intoxication.
Conclusion: Use of polypefan as a component of anti-endotoxin treatment of gestational toxicosis could be useful along with traditional therapy. There is an effective method of treatment in the arsenal of clinicians – enterosorbtion, which allows providing prophylaxis and treatment of the mild gestational toxicosis.
CM. Garbuzenko
KGKP "City Polyclinic №2", Pavlodar
1. Ветров В.В. Гестоз и эфферентная терапия. - Санкт-Петербург. - 2000. - С. 12-20.
2. Лужникова Е.А. Неотложная терапия острых отравлений и эндотоксикозов. - Москва. - 2001. - С. 75-78.
3. Лысенков С.И. Неотложные состояния. - Майкоп. - 2001. - С. 295-320.
Number of Views: 219
Category of articles:
Articles
Bibliography link
С.М. Гарбузенко НЕИНВАЗИВНАЯ ДЕТОКСИКАЦИЯ В ПРОФИЛАКТИКЕ И ЛЕЧЕНИИ ГЕСТОЗОВ ЛЁГКОЙ СТЕПЕНИ //НАУКА И ЗДРАВООХРАНЕНИЕ 2012.№ 1. С. 69-70 С.М.Гарбузенко САҚТАНДЫРУДА УЫТСЫЗДАНДЫРУ ИНВАЗИЯЛЫҚ ЕМЕС ЖӘНЕ ЖЕҢІЛ ДӘРЕЖЕЛІ ГЕСТОЗДІ ЕМДЕУ // NAUKA I DRAVOOKHRANENIE. 2012.№ 1. С. 69-70 S.M. Garbuzenko NON-INVASIVE DETOXIFICATION TREATMENT IN THE PREVENTION OF MILD GESTOSIS // ҒЫЛЫМ ЖӘНЕ ДЕНСАУЛЫҚ САҚТАУ. 2012.№ 1. С. 69-70Related publications:
THE DEMOGRAPHIC, CLINICAL AND SOCIAL CHARACTERISTICS OF PATIENTS WITH SCHIZOPHRENIA AND SCHIZOPHRENIA SPECTRUM DISORDERS
STUDY OF KOMPLAENTNOSTI FOR THERAPY OF PATIENTS WITH A HIGH CORONARY RISK
EARLY DIAGNOSIS OF METABOLIC SYNDROME IN CHILDREN AND TEENAGERS OF № 6 SCHOOL GYMNASIUM OF SEMEY
MONITORING OF EDUCATIONAL LEVEL OF DENTAL STUDENTS IN ORAL CAVITY HEALTH
СТОМАТОЛОГИЧЕСКИЙ СТАТУС ПАЦИЕНТОК НА ФОНЕ ПРИМЕНЕНИЯ СОПРОВОДИТЕЛЬНОЙ ТЕРАПИИ ПРИ ПРОВЕДЕНИИ ПРОТИВООПУХОЛЕВОЙ ХИМИОТЕРАПИИ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ